Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
A new hypothesis suggests that central venous pressure increases and renal encapsulation may be a factor in renal damage due to heart failure, and a novel target for treatment.
This study aimed to estimate and compare the aggregate treatment benefit of pharmacological therapy for HFrEF. Which combination of therapies was most effective in improving outcomes?
What do we know about the role of chloride in the pathophysiology of heart failure? This review aims to elucidate the complex interplay of serum chloride and other electrolytes such as sodium in HF.
Heart failure is common in patients with chronic kidney disease. Might the SGLT-2 inhibitor dapagliflozin reduce the risk of kidney failure and cardiovascular death in these patients?
Mission Statement:
Aligned with the ACC's mission to transform cardiovascular care and improve heart health, the JACC Journals continuously strive to provide the best resources for cardiovascular investigators, clinicians, and specialists at every professional stage.